(3R,4R,5S)-4-acetamido-5-((E)-2-(2-(naphthalen-2-ylthio)acetyl)guanidino)-3-(pentan-3-yloxy)cyclohex-1-enylphosphonic acid

ID: ALA4175602

Chembl Id: CHEMBL4175602

PubChem CID: 145973579

Max Phase: Preclinical

Molecular Formula: C26H35N4O6PS

Molecular Weight: 562.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(P(=O)(O)O)C[C@H](N/C(N)=N/C(=O)CSc2ccc3ccccc3c2)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C26H35N4O6PS/c1-4-19(5-2)36-23-14-20(37(33,34)35)13-22(25(23)28-16(3)31)29-26(27)30-24(32)15-38-21-11-10-17-8-6-7-9-18(17)12-21/h6-12,14,19,22-23,25H,4-5,13,15H2,1-3H3,(H,28,31)(H2,33,34,35)(H3,27,29,30,32)/t22-,23+,25+/m0/s1

Standard InChI Key:  DTOBRSDSPYRGEX-JBRSBNLGSA-N

Alternative Forms

  1. Parent:

    ALA4175602

    ---

Associated Targets(non-human)

NA Neuraminidase (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 562.63Molecular Weight (Monoisotopic): 562.2015AlogP: 3.28#Rotatable Bonds: 10
Polar Surface Area: 163.34Molecular Species: ZWITTERIONHBA: 5HBD: 5
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.34CX Basic pKa: 8.78CX LogP: 1.37CX LogD: 1.31
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.13Np Likeness Score: -0.10

References

1. Hsu PH, Chiu DC, Wu KL, Lee PS, Jan JT, Cheng YE, Tsai KC, Cheng TJ, Fang JM..  (2018)  Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses.,  154  [PMID:29843102] [10.1016/j.ejmech.2018.05.030]

Source